Effectiveness of Trauma Treatment in the Specialist Health Care Services
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Eye movement desensitization and reprocessing, Cognitive therapy for PTSD.
- Who it may be relevant to
- Registry conditions: Post Traumatic Stress Disorder PTSD, Quality of Life, Functional Outcome, Complex Post-Traumatic Stress Disorder. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Norway
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Towards Evidence-based PTSD Care in Norwegian Specialist Health Services - A Randomized Controlled Trial
Overview
Post-traumatic stress disorder (PTSD) is a common mental illness. Treatments for PTSD are regarded as highly effective, but a large-scale, prospective, longitudinal randomized controlled trial comparing the effectiveness of these treatments has been requested by the research community. This study aims to conduct a comprehensive investigation into the effectiveness of two prominent PTSD therapies, eye movement desensitization and reprocessing (EMDR) and cognitive therapy for PTSD (CT-PTSD), within the Norwegian specialist health care services. The study aims to compare the therapy effectiveness, including their impact on comorbid disorders, complex PTSD symptoms, and functional outcomes post-treatment. Patients will be randomly assigned to EMDR or CT-PTSD and given manualized therapy aligned with their treatment goals. Each arm aims to recruit 135 patients, resulting in a total sample size of 270 patients. The main objective of this study is to examine the growth curves of the two methods and how patient characteristics affect their developments. Secondary short-term aims include (1) investigating the impact of EMDR and CT-PTSD on complex PTSD symptoms, (2) assessing effects on other clinical conditions and functional outcomes, and (3) exploring whether the therapeutic alliance mediates treatment effects. Secondary long-term aims are (1) to assess the long-term effects of EMDR and CT-PTSD on PTSD symptoms and (2) to explore the impact of extended or additional treatments on outcomes.
Detailed description
Participants will be recruited from Asker DPS, Bærum DPS, Drammen DPS, and Ringerike DPS. They were referred to DPS for PTSD treatment, either by general practitioners, other primary health care services in their municipality, or psychiatric hospitals. This study is a longitudinal multi-assessment 2-arm RCT and does not include a treatment as usual group. The standard treatment protocol includes up to 24 weekly sessions. Conversely, if no discernible improvement is seen after 10 sessions, it is recommended to terminate treatment. The clinical assessment consists of self-administered questionnaires collected through CheckWare, which is a digital platform developed for healthcare services. They will be asked to report symptoms of PTSD, depression, anxiety, psychosis, alcohol/drug use, functional outcomes, working alliance. Before treatment starts, patients will complete baseline assessments. Throughout the treatment phase, all patients will be requested to fill out self-administered questionnaires after each session.
Interventions
- Behavioral Eye movement desensitization and reprocessing
Psychotherapy with EMDR. A therapist guides the client in recalling distressing events while simultaneously following a stimulus, like a moving light or tapping. The idea is that this bilateral stimulation helps reduce the intensity of the traumatic memory, allowing clients to gain perspective and lessen emotional distress associated with it. The standard treatment protocol includes up to 24 weekly sessions. - Behavioral Cognitive therapy for PTSD
Psychotherapy with CT-PTSD. A therapist works with the client to understand how they interpret their trauma and identify distorted thinking patterns that fuel their PTSD symptoms. Through guided discussions, written exercises, and sometimes "re-living" the trauma in a controlled way, clients learn to reshape these beliefs, gain a more balanced perspective, and reduce symptoms like hypervigilance, flashbacks, and avoidance behaviors. The standard treatment protocol includes up to 24 weekly sessio
Primary outcome measures
- Changes in PTSD-symptoms [Time frame: From enrollment to the end of treatment at 24 weeks. Follow up at 3, 6 and 12 months]
- Changes in PTSD-symptoms [Time frame: From enrollment to the end of treatment at 24 weeks. Follow up at 3, 6 and 12 months]
Secondary outcome measures (7)
- Changes in comorbid illnesses [Time frame: From enrollment to the end of treatment at 24 weeks. Follow up at 3, 6 and 12 months]
- Changes in comorbid illnesses [Time frame: From enrollment to the end of treatment at 24 weeks. Follow up at 3, 6 and 12 months]
- Changes in comorbid illnesses [Time frame: From enrollment to the end of treatment at 24 weeks. Follow up at 3, 6 and 12 months]
- Changes in comorbid illnesses [Time frame: From enrollment to the end of treatment at 24 weeks. Follow up at 3, 6 and 12 months]
- Changes in comorbid illnesses [Time frame: From enrollment to the end of treatment at 24 weeks. Follow up at 3, 6 and 12 months]
- Changes in functional outcomes [Time frame: From enrollment to the end of treatment at 24 weeks. Follow up at 3, 6 and 12 months]
- Changes in functional outcomes [Time frame: From enrollment to the end of treatment at 24 weeks. Follow up at 3, 6 and 12 months]
Eligibility criteria
Inclusion criteria
- age ≥18 years
- meeting criteria for PTSD based on the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) with a total score ≥23
Exclusion criteria
- insufficient mastery of the Norwegian language
- severe intellectual impairment (estimated IQ of 70 or less)
- comorbid psychiatric illnesses in an acute phase where other types of treatment need to be prioritized (e.g. hospitalization)
- history of EMDR or CT-PTSD treatment
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Treatment
Study locations
Norway · 1 center
- Vestre Viken Health Trust — Drammen
Identifiers
NCT: NCT06691347 · REK 716204